Merck interferon-free combination shows high hepatitis C cure rate in early study
Need for expansion of hepatitis C screening among veterans, 'baby-boom' generation and pregnant women highlighted
AbbVie’s two-drug, interferon-free combination cures genotype 1b hepatitis C infection in 95%
High response rates with telaprevir triple therapy for HIV-positive men with acute hepatitis C
In ELECTRON trial, 100% of hard-to-treat patients cured with sofosbuvir/ledipasvir plus ribavirin or GS-9669
HCV reinfection is common among HIV-positive gay men in Europe
Faldaprevir demonstrates good early response in genotype 1 HIV/HCV co-infection
Simeprevir with interferon effective for HIV/HCV co-infected people with genotype 1 hepatitis C
Ensuring good-quality HIV care in Europe: where can we improve?
